Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study

Performance-based cognitive data were collected using the Cognitive Drug Research System in a study of levomilnacipran extended-release (ER) 40–120 mg/day (NCT01034462) in adults with major depressive disorder. These data were analyzed post-hoc to explore the relationship between cognitive measures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wesnes, Keith A., Gommoll, Carl, Chen, Changzheng, Sambunaris, Angelo, McIntyre, Roger S., Harvey, Philip D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265686/
https://www.ncbi.nlm.nih.gov/pubmed/27861191
http://dx.doi.org/10.1097/YIC.0000000000000157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265686/
https://www.ncbi.nlm.nih.gov/pubmed/27861191
http://dx.doi.org/10.1097/YIC.0000000000000157

Ejemplares similares